Sage Therapeutics Inc. sell Citigroup Inc.
Start price
29.05.24
/
50%
€10.05
Target price
29.05.25
€7.37
Performance (%)
-42.75%
End price
30.05.25
€5.75
Summary
This prediction ended on 30.05.25 with a price of €5.75. The SELL prediction by Citigroup_Inc_ for Sage Therapeutics Inc. performed very well with a performance of -42.75%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $8.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten